Immatics IMTX
NASDAQ IMTX
$6.76 +0.34 (+5.29%)
As of: Nov 11, 2026 · 3:03 PM EST

Immatics (IMTX) Other Non Operating Income (2020 - 2022)

Updated

Immatics (IMTX) recorded Other Non Operating Income of -$5.91 million in Q3 2022, compared with -$6.43 million a year earlier.

Analysis

Immatics (IMTX) Other Non Operating Income (2020 - 2022) Analysis & Trends

On a TTM basis, Immatics' Other Non Operating Income came in at $7.83 million as of Sep 30, 2022; for FY2021, it came in at -$13.01 million.

  • Across earlier years, Other Non Operating Income came in at $20.3 million in FY2020.
  • Quarterly Other Non Operating Income has ranged from -$6.43 million in Q3 2021 to $18.55 million in Q1 2022 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$2.97 million (Q2 2022), $18.55 million (Q1 2022) and -$1.83 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immatics 860.74 Mn -1.20 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -5.91 Mn
Jun 30, 2022 -2.97 Mn
Mar 31, 2022 18.55 Mn
Dec 31, 2021 -1.83 Mn
Sep 30, 2021 -6.43 Mn
Jun 30, 2021 -3.28 Mn
Mar 31, 2021 -1.47 Mn
Dec 31, 2020 5.51 Mn
Sep 30, 2020 15.37 Mn
API Access

Immatics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IMTX&period=max&api_key=YOUR_API_KEY